CD274 and nevus comedonicus syndrome: Given that the PD-1/PD-L1 blockade has now also been successfully tested in NC patients [44], a triple combinatorial approach consisting of T-VEC, iBET compounds, and immune checkpoint inhibitors may further improve therapeutic efficacy.